Target intelligence / Profile preview

general transcription factor IIIA pseudogene 2 (GTF3AP2)

Target
GTF3AP2
Molecular classification
Other (Pseudogene)
01

Overview

General transcription factor IIIA pseudogene 2 (GTF3AP2) is a human gene classified as a pseudogene, meaning it does not encode a functional protein product. It is named for its genomic similarity to the general transcription factor IIIA (GTF3A) gene, but unlike GTF3A, GTF3AP2 is not expressed as a functional protein and its biological role, if any, remains unclear[7][8]. Pseudogenes can sometimes be transcribed, but they do not typically produce functional proteins, and their relevance as therapeutic or diagnostic targets is very limited. There are no known associated diseases, molecular interactions, or clinical applications for GTF3AP2. Some sources mention possible regulatory RNA effects in specific contexts, such as erythroid differentiation, but there is currently no recognized disease implication or drug interaction[6]. The gene is located on chromosome 14 (positions 71,044,375-71,044,640, reverse strand)[7]. This is not considered a therapeutic target (e.g., receptor, enzyme, transporter) and should not be included as such. The name and abbreviation are correct, but it is a pseudogene, thus generally excluded from lists of actionable drug targets. There is no evidence for function, disease relevance, or druggability in current biomedical literature[7][8][6].

Other names
GTF3AP2general transcription factor IIIA pseudogene 2

Beyond the preview

Go deeper on general transcription factor IIIA pseudogene 2 (GTF3AP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on general transcription factor IIIA pseudogene 2 (GTF3AP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call